We are holding on to biotech, as we still think it has good longer-term potential. Though many stocks dropped at the end of last week, biotech dropped less than large-cap stocks, indicating strength.
Related posts:
Financial advisory newsletters with consistently high long-term returns™
We are holding on to biotech, as we still think it has good longer-term potential. Though many stocks dropped at the end of last week, biotech dropped less than large-cap stocks, indicating strength.
Related posts:
0 Response to “Holding on to biotech”